Cargando…

Pleural Effusion in COVID-19 Pneumonia: Clinical and Prognostic Implications—An Observational, Retrospective Study

Background: COVID-19 presents with a wide spectrum of clinical and radiological manifestations, including pleural effusion. The prevalence and prognostic impact of pleural effusion are still not entirely clear. Patients and methods: This is a retrospective, single-center study including a population...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappelli, Sara, Casto, Elisabetta, Lomi, Marta, Pagano, Alessandra, Gabbrielli, Luciano, Pancani, Roberta, Aquilini, Ferruccio, Gemignani, Giulia, Carrozzi, Laura, Celi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917650/
https://www.ncbi.nlm.nih.gov/pubmed/36769697
http://dx.doi.org/10.3390/jcm12031049
_version_ 1784886418761318400
author Cappelli, Sara
Casto, Elisabetta
Lomi, Marta
Pagano, Alessandra
Gabbrielli, Luciano
Pancani, Roberta
Aquilini, Ferruccio
Gemignani, Giulia
Carrozzi, Laura
Celi, Alessandro
author_facet Cappelli, Sara
Casto, Elisabetta
Lomi, Marta
Pagano, Alessandra
Gabbrielli, Luciano
Pancani, Roberta
Aquilini, Ferruccio
Gemignani, Giulia
Carrozzi, Laura
Celi, Alessandro
author_sort Cappelli, Sara
collection PubMed
description Background: COVID-19 presents with a wide spectrum of clinical and radiological manifestations, including pleural effusion. The prevalence and prognostic impact of pleural effusion are still not entirely clear. Patients and methods: This is a retrospective, single-center study including a population of consecutive patients admitted to the University Hospital of Cisanello (Pisa) from March 2020 to January 2021 with a positive SARS-CoV-2 nasopharyngeal swab and SARS-CoV-2-related pneumonia. The patients were divided into two populations based on the presence (n = 150) or absence (n = 515) of pleural effusion on chest CT scan, excluding patients with pre-existing pleural effusion. We collected laboratory data (hemoglobin, leukocytes, platelets, C-reactive protein, procalcitonin), worst PaO(2)/FiO(2) ratio as an index of respiratory gas exchange impairment, the extent of interstitial involvement related to SARS-CoV-2 pneumonia and data on intensity of care, length of stay and outcome (discharge or death). Results: The prevalence of pleural effusion was 23%. Patients with pleural effusion showed worse gas exchange (p < 0.001), longer average hospital stay (p < 0.001), need for more health care resources (p < 0.001) and higher mortality (p < 0.001) compared to patients without pleural effusion. By multivariate analysis, pleural effusion was found to be an independent negative prognostic factor compared with other variables such as increased C-reactive protein, greater extent of pneumonia and older age. Pleural effusion was present at the first CT scan in most patients (68%). Conclusions: Pleural effusion associated with SARS-CoV-2 pneumonia is a relatively frequent finding that is confirmed to be a negative prognostic factor. Identifying early prognostic factors in an endemic-prone disease such as COVID-19 is necessary to optimize its clinical management. Further clinical studies aimed at better characterizing pleural effusion in these patients will be appropriate in order to clarify its pathogenetic role.
format Online
Article
Text
id pubmed-9917650
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99176502023-02-11 Pleural Effusion in COVID-19 Pneumonia: Clinical and Prognostic Implications—An Observational, Retrospective Study Cappelli, Sara Casto, Elisabetta Lomi, Marta Pagano, Alessandra Gabbrielli, Luciano Pancani, Roberta Aquilini, Ferruccio Gemignani, Giulia Carrozzi, Laura Celi, Alessandro J Clin Med Article Background: COVID-19 presents with a wide spectrum of clinical and radiological manifestations, including pleural effusion. The prevalence and prognostic impact of pleural effusion are still not entirely clear. Patients and methods: This is a retrospective, single-center study including a population of consecutive patients admitted to the University Hospital of Cisanello (Pisa) from March 2020 to January 2021 with a positive SARS-CoV-2 nasopharyngeal swab and SARS-CoV-2-related pneumonia. The patients were divided into two populations based on the presence (n = 150) or absence (n = 515) of pleural effusion on chest CT scan, excluding patients with pre-existing pleural effusion. We collected laboratory data (hemoglobin, leukocytes, platelets, C-reactive protein, procalcitonin), worst PaO(2)/FiO(2) ratio as an index of respiratory gas exchange impairment, the extent of interstitial involvement related to SARS-CoV-2 pneumonia and data on intensity of care, length of stay and outcome (discharge or death). Results: The prevalence of pleural effusion was 23%. Patients with pleural effusion showed worse gas exchange (p < 0.001), longer average hospital stay (p < 0.001), need for more health care resources (p < 0.001) and higher mortality (p < 0.001) compared to patients without pleural effusion. By multivariate analysis, pleural effusion was found to be an independent negative prognostic factor compared with other variables such as increased C-reactive protein, greater extent of pneumonia and older age. Pleural effusion was present at the first CT scan in most patients (68%). Conclusions: Pleural effusion associated with SARS-CoV-2 pneumonia is a relatively frequent finding that is confirmed to be a negative prognostic factor. Identifying early prognostic factors in an endemic-prone disease such as COVID-19 is necessary to optimize its clinical management. Further clinical studies aimed at better characterizing pleural effusion in these patients will be appropriate in order to clarify its pathogenetic role. MDPI 2023-01-29 /pmc/articles/PMC9917650/ /pubmed/36769697 http://dx.doi.org/10.3390/jcm12031049 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cappelli, Sara
Casto, Elisabetta
Lomi, Marta
Pagano, Alessandra
Gabbrielli, Luciano
Pancani, Roberta
Aquilini, Ferruccio
Gemignani, Giulia
Carrozzi, Laura
Celi, Alessandro
Pleural Effusion in COVID-19 Pneumonia: Clinical and Prognostic Implications—An Observational, Retrospective Study
title Pleural Effusion in COVID-19 Pneumonia: Clinical and Prognostic Implications—An Observational, Retrospective Study
title_full Pleural Effusion in COVID-19 Pneumonia: Clinical and Prognostic Implications—An Observational, Retrospective Study
title_fullStr Pleural Effusion in COVID-19 Pneumonia: Clinical and Prognostic Implications—An Observational, Retrospective Study
title_full_unstemmed Pleural Effusion in COVID-19 Pneumonia: Clinical and Prognostic Implications—An Observational, Retrospective Study
title_short Pleural Effusion in COVID-19 Pneumonia: Clinical and Prognostic Implications—An Observational, Retrospective Study
title_sort pleural effusion in covid-19 pneumonia: clinical and prognostic implications—an observational, retrospective study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917650/
https://www.ncbi.nlm.nih.gov/pubmed/36769697
http://dx.doi.org/10.3390/jcm12031049
work_keys_str_mv AT cappellisara pleuraleffusionincovid19pneumoniaclinicalandprognosticimplicationsanobservationalretrospectivestudy
AT castoelisabetta pleuraleffusionincovid19pneumoniaclinicalandprognosticimplicationsanobservationalretrospectivestudy
AT lomimarta pleuraleffusionincovid19pneumoniaclinicalandprognosticimplicationsanobservationalretrospectivestudy
AT paganoalessandra pleuraleffusionincovid19pneumoniaclinicalandprognosticimplicationsanobservationalretrospectivestudy
AT gabbrielliluciano pleuraleffusionincovid19pneumoniaclinicalandprognosticimplicationsanobservationalretrospectivestudy
AT pancaniroberta pleuraleffusionincovid19pneumoniaclinicalandprognosticimplicationsanobservationalretrospectivestudy
AT aquiliniferruccio pleuraleffusionincovid19pneumoniaclinicalandprognosticimplicationsanobservationalretrospectivestudy
AT gemignanigiulia pleuraleffusionincovid19pneumoniaclinicalandprognosticimplicationsanobservationalretrospectivestudy
AT carrozzilaura pleuraleffusionincovid19pneumoniaclinicalandprognosticimplicationsanobservationalretrospectivestudy
AT celialessandro pleuraleffusionincovid19pneumoniaclinicalandprognosticimplicationsanobservationalretrospectivestudy